Fundz

ai3Bio reported raising $48.3 Million in an initial SEC Form D filing, from an offering of $48.3 Million

PRIVATESep 29, 2026

Amount Raised

$48.3 Million

$48.3 Million sold, per SEC Form D (first sale Jun 9, 2026)
$48 Million per company press release (Sep 29, 2026)

Round Type

Series A

WatertownBiotechnologyHealth Care

Description

ai3Bio has launched with $48 million in Series A funding. This capital will be used to advance their platforms targeting Th17 cells in vivo. The company aims to reset the immune system at its root. The funding marks a significant step for ai3Bio.

Quick answer

ai3Bio raised $48.3 Million in a Series A round, dated September 29, 2026. ai3Bio is based in Watertown, Massachusetts, United States.

How much did ai3Bio raise?
ai3Bio raised $48.3 Million in a Series A round on September 29, 2026.
What does ai3Bio do?
ai3Bio is a biotechnology company focused on resetting the immune system.
Where is ai3Bio based and how big is it?
ai3Bio is based in Watertown, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as ai3Bio that raised within 45 days of this round, from Fundz verified event records.

  • Yicura BioMed raised an undisclosed amount (Series B) on November 13, 2026.
  • Boston Medical Sciences raised $35M (Series B) on November 13, 2026.
  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.

Who to call at ai3Bio, and when

A new round usually means ai3Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ai3Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ai3Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ai3Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ai3Bio

Location

Watertown, Massachusetts, United States

About

ai3Bio is a biotechnology company focused on resetting the immune system. The company aims to advance therapeutic platforms targeting Th17 cells in vivo. They have recently launched with significant Series A funding to support their innovative solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ai3Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ai3Bio's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

ai3Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.